
|Articles|March 1, 2006
- Volume 0 0
NCPA IDENTIFIES PRIORITIES
Advertisement
The National Community PharmacistsAssociation (NCPA) is fighting against thecommoditization of pharmacy, the marginalizationof pharmacists as front-line healthcare providers, and the concentration ofpower over the pharmacy benefit in thehands of third-party intermediaries. Therefore,NCPA is directing its resources to focuson fundamental priorities that will protectthe long-term interests of pharmacists andbegin to redefine the pharmacy profession.The priorities include the following:
- Enlisting and leveraging the grass-rootspower of >24,000 independent pharmacists
- Demonstrating the value of pharmacistsin the health care delivery system
- Enacting HR-1671, the pharmacynegotiation bill, to create a level playingfield for pharmacists by allowingthem to negotiate with pharmacybenefit managers
- Working with state governments torecognize the value of pharmacists andguarantee fair compensation for theirprofessional services so that patientscontinue to have access to medicationand to community pharmacists
- Lobbying for legislative amendments tothe Medicare Part D prescription drugprogram
- Encouraging broad adoption by communitypharmacies of electronic prescribingtechnology
Articles in this issue
over 20 years ago
British Poll Shows People Denying Weight Problemsover 20 years ago
Suing a Lawyer for Malpractice?over 20 years ago
Pharmacists—Cops or Not? (Part 1)over 20 years ago
Can You Read These Rxs?over 20 years ago
Alternative Measures for Treating Pediculosisover 20 years ago
Compounding Hotlineover 20 years ago
Obesity May Lead to Kidney Failureover 20 years ago
Body Fat Associated with Alzheimer's Proteinover 20 years ago
Midlife Obesity May Cause Heart Diseaseover 20 years ago
The Evolution of Imprint IdentificationAdvertisement
Related to this article

How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.

At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.

Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.

Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.

Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.

As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.

Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Preparing Pharmacists for Psychedelic Medicine
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
Could Cemdisiran Keep Patients With Myasthenia Gravis Out of the Hospital?
5

